Jamieson Wellness (TSE:JWEL) Hits New 1-Year High on Analyst Upgrade

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) shares hit a new 52-week high during trading on Friday after Royal Bank of Canada raised their price target on the stock from C$37.00 to C$38.00. The stock traded as high as C$35.90 and last traded at C$35.63, with a volume of 75172 shares trading hands. The stock had previously closed at C$33.68.

A number of other brokerages have also recently issued reports on JWEL. Canaccord Genuity Group upped their target price on Jamieson Wellness from C$32.50 to C$36.25 in a report on Friday, August 9th. BMO Capital Markets raised their price objective on shares of Jamieson Wellness from C$35.00 to C$42.00 in a report on Friday, August 9th. Finally, TD Securities upped their price target on shares of Jamieson Wellness from C$40.00 to C$42.00 and gave the company a "buy" rating in a research report on Friday.

Insider Activity

In other Jamieson Wellness news, Director Michael Al Pilato sold 24,465 shares of the business's stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of C$33.41, for a total transaction of C$817,380.54. In related news, Director Michael Al Pilato sold 24,465 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of C$33.41, for a total transaction of C$817,380.54. Also, Senior Officer Regan Stewart sold 8,732 shares of Jamieson Wellness stock in a transaction dated Monday, August 26th. The stock was sold at an average price of C$31.65, for a total transaction of C$276,373.04. Insiders sold 72,058 shares of company stock worth $2,307,317 over the last three months. 0.26% of the stock is currently owned by insiders.

Jamieson Wellness Stock Up 5.8 %

The company has a debt-to-equity ratio of 92.76, a current ratio of 3.21 and a quick ratio of 1.08. The company has a fifty day moving average price of C$33.95 and a 200 day moving average price of C$30.60. The company has a market cap of C$1.48 billion, a PE ratio of 41.42 and a beta of 0.63.

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.